Long Term Follow-up for RGX-202

Clinical trial NCT06491927 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06491927
Sponsor: REGENXBIO Inc.
Status: ENROLLING_BY_INVITATION
Study type: OBSERVATIONAL

Duchenne Muscular Dystrophy

Start date: 2024-05-08
Primary completion: 2029-12-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.